Kaštelan, S.; Antunica, A.G.; Konjevoda, S.; Tomić, Z.; Sarić, A.; Kulaš, M.; Kulaš, L.; Begović, E.K.; Čanović, S.; Kovačević, P.;
et al. Mitochondrial ROS in Retinal Neurodegeneration: Thresholds, Quality Control Failure, and Precision Therapeutic Windows. Biomolecules 2026, 16, 445.
https://doi.org/10.3390/biom16030445
AMA Style
Kaštelan S, Antunica AG, Konjevoda S, Tomić Z, Sarić A, Kulaš M, Kulaš L, Begović EK, Čanović S, Kovačević P,
et al. Mitochondrial ROS in Retinal Neurodegeneration: Thresholds, Quality Control Failure, and Precision Therapeutic Windows. Biomolecules. 2026; 16(3):445.
https://doi.org/10.3390/biom16030445
Chicago/Turabian Style
Kaštelan, Snježana, Antonela Gverović Antunica, Suzana Konjevoda, Zora Tomić, Ana Sarić, Marjan Kulaš, Lorena Kulaš, Emina Kujundžić Begović, Samir Čanović, Petra Kovačević,
and et al. 2026. "Mitochondrial ROS in Retinal Neurodegeneration: Thresholds, Quality Control Failure, and Precision Therapeutic Windows" Biomolecules 16, no. 3: 445.
https://doi.org/10.3390/biom16030445
APA Style
Kaštelan, S., Antunica, A. G., Konjevoda, S., Tomić, Z., Sarić, A., Kulaš, M., Kulaš, L., Begović, E. K., Čanović, S., Kovačević, P., & Ivanković, M.
(2026). Mitochondrial ROS in Retinal Neurodegeneration: Thresholds, Quality Control Failure, and Precision Therapeutic Windows. Biomolecules, 16(3), 445.
https://doi.org/10.3390/biom16030445
